Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Other Accumulated Expenses (2022 - 2025)

Historic Other Accumulated Expenses for Sanara MedTech (SMTI) over the last 4 years, with Q3 2025 value amounting to $228001.0.

  • Sanara MedTech's Other Accumulated Expenses fell 8804.12% to $228001.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $228001.0, marking a year-over-year decrease of 8804.12%. This contributed to the annual value of $1.1 million for FY2023, which is 540.73% down from last year.
  • According to the latest figures from Q3 2025, Sanara MedTech's Other Accumulated Expenses is $228001.0, which was down 8804.12% from $39659.0 recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Other Accumulated Expenses registered a high of $1.9 million during Q3 2024, and its lowest value of $39659.0 during Q2 2025.
  • In the last 4 years, Sanara MedTech's Other Accumulated Expenses had a median value of $989744.0 in 2023 and averaged $888853.3.
  • In the last 5 years, Sanara MedTech's Other Accumulated Expenses soared by 9065.5% in 2024 and then crashed by 9634.66% in 2025.
  • Over the past 4 years, Sanara MedTech's Other Accumulated Expenses (Quarter) stood at $1.2 million in 2022, then dropped by 5.41% to $1.1 million in 2023, then surged by 73.32% to $1.9 million in 2024, then plummeted by 88.04% to $228001.0 in 2025.
  • Its last three reported values are $228001.0 in Q3 2025, $39659.0 for Q2 2025, and $1.9 million during Q3 2024.